High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma
Philipp Baumeister(University of Lucerne), Olivier Gires(LMU Klinikum)
Cited by 44
Related Papers
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
|PLoS Biology|2018|97
SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival
|Molecular Oncology|2021|28
CD133 induces tumour-initiating properties in HEK293 cells
|Tumor Biology|2012|23
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy
|World Journal of Urology|2019|17
Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma
|npj Precision Oncology|2025|6